InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Gemayel Georges, Director. Officer active across 1 company, notably Supernus Pharmaceuticals, INC.. Aggregated, 9 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €572k. History available since 19 February 2022. The latest transaction was filed on 5 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gemayel Georges
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
10,000 股@ US$53.710.016% mcap50.0% 占其流量Common StockSEC:0001256088-26-000006:0
15,000 股@ US$12.9816.4% 占其流量Common StockSEC:0001256088-26-000004:0
5,369 股0Common StockSEC:0001628280-25-007463:0
10,787 股@ US$11.468.8% 占其流量Common StockSEC:0001628280-24-047145:0
14,213 股@ US$11.4611.7% 占其流量Common StockSEC:0001628280-24-046666:0
3,886 股@ US$31.338.5% 占其流量Common StockSEC:0001628280-24-040598:0
3,886 股0Common StockSEC:0001104659-24-028279:0
3,882 股0Common StockSEC:0001104659-23-025380:0
4,222 股0Common StockSEC:0001104659-22-026103:0
9 条申报中的 9 条
About Gemayel Georges
Georges Gemayel is a Board Member at Supernus Pharmaceuticals, Inc. He provides expertise in corporate governance and strategy. His role on the board is essential for guiding strategic decisions and ensuring the company's regulatory compliance. Georges Gemayel is recognized for his ability to analyze market trends and advise on best management practices.
